Continued Treatment for Participants Enrolled in Studies of BXQ-350

NCT04404569 · clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
5
Enrollment
INDUSTRY
Sponsor class

Stopped Bexion Pharmaceuticals no longer has open studies in which subjects would be eligible to rollover and continue treatment under the BXQ-350.AE protocol. Therefore, no additional subjects will be enrolled in this trial.

Conditions

Interventions

Sponsor

Bexion Pharmaceuticals, Inc.

Collaborators